King's College London

Research portal

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations

Research output: Contribution to journalReview article

Philip R. Schauer, Zubaidah Nor Hanipah, Francesco Rubino

Original languageEnglish
Pages (from-to)S47-S56
JournalCleveland Clinic Journal of Medicine
Volume84
Issue number7
DOIs
Publication statusPublished - 1 Jul 2017

King's Authors

Abstract

The term metabolic surgery describes bariatric surgical procedures used primarily to treat type 2 diabetes and related metabolic conditions. Originally, bariatric surgery was used as an alternative weight-loss therapy for patients with severe obesity, but clinical data revealed its metabolic benefits in patients with type 2 diabetes. Metabolic surgery is more effective than lifestyle or medical management in achieving glycemic control, sustained weight loss, and reducing diabetes comorbidities. Perioperative adverse events are similar to other gastrointestinal surgeries. New guidelines for type 2 diabetes expand use of metabolic surgery to patients with a lower body mass index.

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454